GPCR

News Weight Loss Drugs Market Is Crowded But Structure Therapeutics CEO Has A Strategy For It

14d ago

News Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

14d ago

News Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?

14d ago

News Structure Therapeutics (GPCR) Rallying on Obesity Drug Data

14d ago

News Structure Therapeutics Obesity Candidate Is 'Very Competitive' To Eli Lilly's Orforglipron, Analyst Says

14d ago

News Structure Therapeutics rises on mid-stage data for oral GLP-1

78d ago

News Structure Weight-Loss Pill Results Rival Novo, Lilly Treatments

78d ago

News Structure Therapeutics reports Q4 results

95d ago

Scanner Unusual volume (2.9x average)

117d ago

News Structure Therapeutics gains on report suggesting it may be a top takeover target

122d ago

News Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why

137d ago

News Structure Therapeutics Is Bracing for Copycat Weight-Loss Pills

138d ago

News Powell Casts DOJ Subpoenas As Political Pressure, Warriors Up for Sale | Bloomberg Markets 1/12/2026

140d ago

News Genentech enters $100M deal with Structure Therapeutics for GLP-1 weight-loss drug

147d ago